Reducing Disparities in Medication Adherence in SLE

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-02

Study Completion Date

2020-06-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intervention to Improve Communication and Medication Adherence in Lupus

NCT06458075

Systemic Lupus Erythematosus

RECRUITING NA

Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)

NCT05426902

Systemic Lupus Erythematosus

COMPLETED NA

Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus

NCT03218033

Systemic Lupus

COMPLETED NA

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

NCT00000421

Systemic Lupus Erythematosus

COMPLETED PHASE2

Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment

NCT07102030

Systemic Lupus Erythematosus

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Lupus Erythematosus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention arm

Lupus clinic providers will use Surescripts refill information to assess adherence level and address adherence barriers. We will assess the feasibility and acceptability of the intervention.

Group Type EXPERIMENTAL

Behavioral Intervention

Intervention Type BEHAVIORAL

Lupus clinic providers will be prompted to assess adherence level using Surescripts refill information and address any adherence barriers that arise during the clinical encounter.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral Intervention

Lupus clinic providers will be prompted to assess adherence level using Surescripts refill information and address any adherence barriers that arise during the clinical encounter.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All followup patients seen at the Duke Lupus clinic

Exclusion Criteria

* Patients not seen at the Duke Lupus Clinic
* New patients seen for the first time at the Duke Lupus Clinic
* Patients who are not prescribed any lupus medications

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No